Infliximab as first-line therapy for Crohn's disease

被引：0
|
作者：
Bernstein, CN
机构：
来源：
INFLAMMATORY BOWEL DISEASES | 2002年 / 8卷 / 01期
关键词：
D O I：
10.1097/00054725-200201000-00012
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：63 / 65
页数：3
相关论文
共 50 条
  • [41] Infliximab therapy and surgical intervention for Crohn's disease
    Hashida, Hiroki
    Omori, Ayaka
    Matsubara, Takaaki
    Kitano, Shoichi
    Kumata, Yukiko
    Masui, Hideyuki
    Kita, Ryosuke
    Iwamura, Sena
    Hosotani, Ryo
    Kaihara, Satoshi
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 183 - 183
  • [42] Sarcoidosis during infliximab therapy for Crohn's disease
    Takahashi, Hidetoshi
    Kaneta, Kazuhiro
    Honma, Masaru
    Ishida-Yamamoto, Akemi
    Ashida, Tomonori
    Kohgo, Yutaka
    Ohsaki, Yoshinobu
    Iizuka, Hajime
    JOURNAL OF DERMATOLOGY, 2010, 37 (05): : 471 - 474
  • [43] Metastatic Crohn's disease despite infliximab therapy
    Campos, Sara
    Coutinho, Ines
    Cardoso, Jose Carlos
    Portela, Francisco
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2017, 92 (05) : 104 - 106
  • [44] Infliximab therapy in Crohn's disease: a pragmatic approach?
    Kevans, D.
    Keegan, D.
    Mulcahy, H. E.
    O'Donoghue, D. P.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (02) : 351 - 359
  • [45] Infliximab therapy in pediatric Crohn's disease: a review
    Parashette, Kalyan Ray
    Makam, Raghavendra Charan
    Cuffari, Carmen
    CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY, 2010, 3 : 57 - 63
  • [46] Maintenance therapy with subcutaneous infliximab for Crohn's disease
    Gomersall, Bethany
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2023, 8 (07): : 608 - 608
  • [47] Demyelination during infliximab therapy for Crohn's disease
    An, Y. K.
    Allsopp, S.
    Daveson, K. L.
    Daveson, A. J. M.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 155 - 155
  • [48] Infliximab Therapy and Surgical Intervention for Crohn's Disease
    Hashida, Hiroki
    Kitano, Shoichi
    Kumata, Yukiko
    Kita, Ryosuke
    Masui, Hideyuki
    Sakamoto, Yusuke
    Kinoshita, Hiromitsu
    Iwamoto, Sena
    Mizumoto, Motoko
    Kondo, Masato
    Komori, Junji
    Kobayashi, Hiroyuki
    Uryuhara, Kenji
    Hosotani, Ryo
    Kaihara, Satoshi
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S767 - S767
  • [49] Serum inflammatory protein profiling to corroborate selection of therapy naive moderate-to-severe pediatric Crohn's disease patients eligible for first-line infliximab treatment
    Jongsma, M. M. E.
    Costes, L. M. M.
    Tindemans, I.
    Cozijnsen, M. A.
    Raatgreep, R. H. C.
    van Pieterson, M.
    Li, Y.
    Escher, J. C.
    de Ridder, L.
    Samsom, J. N.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I197 - I198
  • [50] Adalimumab as first-line anti-TNF treatment in pediatric Crohn's disease
    Martin-de-Carpi, J.
    Navas-Lopez, V. M.
    Navalon-Rubio, M.
    Llerena-Santa-Cruz, E.
    Gil-Ortega, D.
    Varea-Calderon, V.
    Sierra-Salinas, C.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S309 - S309
12345